Inventor · disambiguated record
Liang Liu
Also filed as: LIU LIANG · Liu liang feng
50 granted patents·21 pending applications·76 citations·filing 2004–2024
97Inventor score
Files withUNIV MACAU SCI & TECH54SUNSHINE LAKE PHARMA CO LTD5LIU LIANG4UNIV HONG KONG BAPTIST3UNIV FUDAN2
Top patents by PatentIndex Score
71 records- 0195US9782400B2Oncogenic ROS1 and ALK kinase inhibitorUNIV MACAU SCI & TECH·Filed 2015·Granted Oct 10, 2017·18 cites·17 claims
- 0294US10278955B1Methods of treating cancerUNIV MACAU SCI & TECH·Filed 2017·Granted May 7, 2019·7 cites·2 claims
- 0393US9744145B1Methods for treating lung cancerUNIV MACAU SCI & TECH·Filed 2017·Granted Aug 29, 2017·30 cites·19 claims
- 0482US10155721B2Lignanamides and a method of treating neurodegenerative diseases by using the sameUNIV MACAU SCI & TECH·Filed 2017·Granted Dec 18, 2018·2 cites·4 claims
- 0581US9861623B1Combination treatment of RAS-positive diseases with PDE-δ inhibitor and direct autophagy inhibitorUNIV MACAU SCI & TECH·Filed 2016·Granted Jan 9, 2018·4 cites·20 claims
- 0680US10787708B2Method of identifying a gene associated with a disease or pathological condition of the diseaseUNIV MACAU SCI & TECH·Filed 2017·Granted Sep 29, 2020·2 cites·12 claims
- 0780US7544668B2Saponins derived from Ilex pubescens and method of purifying the sameUNIV HONG KONG BAPTIST·Filed 2006·Granted Jun 9, 2009·1 cites·12 claims
- 0878US11679143B2FGF21 variant, fusion protein and application thereofSUNSHINE LAKE PHARMA CO LTD·Filed 2019·Granted Jun 20, 2023·2 cites·19 claims
- 0975US9522125B1Method of treating cancerUNIV MACAU SCI & TECH·Filed 2015·Granted Dec 20, 2016·2 cites·6 claims
- 1074US9901566B1Limonoids for treating autoimmune diseasesUNIV MACAU SCI & TECH·Filed 2017·Granted Feb 27, 2018·1 cites·19 claims
- 1173US9051348B2Ginsenoside with anti-cancer activity and the preparation method thereofUNIV MACAU SCI & TECH·Filed 2013·Granted Jun 9, 2015·2 cites·13 claims
- 1273US9005677B2Autophagy enhancer for treatment of neurodegenerative diseasesUNIV MACAU SCI & TECH·Filed 2014·Granted Apr 14, 2015·1 cites·1 claims
- 1372US2025084144A1Dual-target fusion proteins comprising fgf21 and glp-1, connected through a fc portion of an immunoglobulinSUNSHINE LAKE PHARMA CO LTD·Filed 2024·Application pending·0 cites
- 1471US9884047B1Method of treating lung cancerUNIV MACAU SCI & TECH·Filed 2017·Granted Feb 6, 2018·1 cites·20 claims
- 1571US9375457B2Composition comprising Rhizoma coptidis, Cortex phellodendri and Fructus gardeniae and for treating neurodegenerative diseasesUNIV HONG KONG BAPTIST·Filed 2014·Granted Jun 28, 2016·1 cites·10 claims
- 1668US10702500B2Methods of treating cancerUNIV MACAU SCI & TECH·Filed 2019·Granted Jul 7, 2020·0 cites·7 claims
- 1768US10322097B2Treatment of subjects with multidrug-resistant cancerUNIV MACAU SCI & TECH·Filed 2015·Granted Jun 18, 2019·2 cites·13 claims
- 1864US9119847B2Neferine and the use thereof in treating huntington diseaseUNIV MACAU SCI & TECH·Filed 2014·Granted Sep 1, 2015·0 cites·2 claims
- 1964US2015190392A1Group of Alkaloids, the Novel Autophagic Enhancers for Treatment of Cancers and Neurodegenerative Conditions ThereofUNIV MACAU SCI & TECH·Filed 2014·Application pending·0 cites
- 2063US2025382376A1Nanobody and nanobody-drug conjugate targeting cd73, method for preparing same, and use thereofUNIV FUDAN·Filed 2023·Application pending·0 cites
- 2160US10900966B2Use of glycan as biomarkers for autoimmune diseasesUNIV MACAU SCI & TECH·Filed 2019·Granted Jan 26, 2021·0 cites·13 claims
- 2260US9561221B2Group of alkaloids, the novel autophagic enhancers for treatment of cancers and neurodegenerative conditions thereofUNIV MACAU SCI & TECH·Filed 2015·Granted Feb 7, 2017·0 cites·9 claims
- 2360US9561219B2Group of alkaloids, the novel autophagic enhancers for treatment of cancers and neurodegenerative conditions thereofUNIV MACAU SCI & TECH·Filed 2015·Granted Feb 7, 2017·0 cites·5 claims
- 2460US9561223B2Group of alkaloids, the novel autophagic enhancers for treatment of cancers and neurodegenerative conditions thereofUNIV MACAU SCI & TECH·Filed 2015·Granted Feb 7, 2017·0 cites·3 claims
- 2560US9561220B2Group of alkaloids, the novel autophagic enhancers for treatment of cancers and neurodegenerative conditions thereofUNIV MACAU SCI & TECH·Filed 2015·Granted Feb 7, 2017·0 cites·3 claims
- 2660US9561222B2Group of alkaloids, the novel autophagic enhancers for treatment of cancers and neurodegenerative conditions thereofUNIV MACAU SCI & TECH·Filed 2015·Granted Feb 7, 2017·0 cites·3 claims
- 2760US8551541B2Disinfectant making air fresh and preparation and method and use thereofLIU LIANG·Filed 2009·Granted Oct 8, 2013·0 cites·25 claims
- 2859US10208028B1Methods of treating cancerUNIV MACAU SCI & TECH·Filed 2017·Granted Feb 19, 2019·0 cites·9 claims
- 2958US9018196B2Development of a new formulation overcoming thymus atrophy with concomitantly enhancement of anti-inflammatory effect of dexamethasoneUNIV MACAU SCI & TECH·Filed 2014·Granted Apr 28, 2015·0 cites·11 claims
- 3057US10265298B2Method of increasing the bioavailability of silybinUNIV MACAU SCI & TECH·Filed 2017·Granted Apr 23, 2019·0 cites·12 claims
- 3155US9364469B1Identification of a new AMPK activator for treatment of lung cancerUNIV MACAU SCI & TECH·Filed 2015·Granted Jun 14, 2016·0 cites·6 claims
- 3255US9273088B2Ginsenoside derivative compounds and the use thereof in protection against ischemia/reperfusion injuryUNIV MACAU SCI & TECH·Filed 2013·Granted Mar 1, 2016·0 cites·2 claims
- 3354US9675608B2Identification of natural small-molecules AMPK activators for treatment of cancers or multidrug-resistant cancersUNIV MACAU SCI & TECH·Filed 2015·Granted Jun 13, 2017·0 cites·9 claims
- 3454US2023338491A1Method for screening individual tumor neoantigen peptide, and vaccine formulation thereofHANGZHOU NEOANTIGEN THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 3554US2024165202A1Uses of fgf21 polypeptides and fusion polypeptides thereofSUNSHINE LAKE PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 3653US12145974B2Dual-target fusion proteins comprising FGF21 and GLP-1, connected through a Fc portion of an immunoglobulinSUNSHINE LAKE PHARMA CO LTD·Filed 2018·Granted Nov 19, 2024·0 cites·18 claims
- 3753US9808477B2Use of nobiletin in cancer treatmentUNIV MACAU SCI & TECH·Filed 2015·Granted Nov 7, 2017·0 cites·8 claims
- 3853US2014371254A1Novel treatment of gefitinib-resistant non-small-cell lung cancerUNIV MACAU SCI & TECH·Filed 2014·Application pending·0 cites
- 3952US12024565B2Targeted CD73 antibody and antibody-drug conjugate, and preparation method therefor and uses thereofUNIV FUDAN·Filed 2019·Granted Jul 2, 2024·0 cites·12 claims
- 4052US9604987B2Synthesis of autophagy inducing compound and the uses thereofUNIV HONG KONG BAPTIST UNIV·Filed 2015·Granted Mar 28, 2017·0 cites·9 claims
- 4152US9439898B2Methods for novel drug discovery, treatment and selective targeting for gefitinib-resistant non-small-cell lung cancer harboring T790M mutationUNIV MACAU SCI & TECH·Filed 2014·Granted Sep 13, 2016·0 cites·9 claims
- 4252US2023357411A1Humanized anti-trka antibodies and uses thereofSUNSHINE LAKE PHARMA CO LTD·Filed 2021·Application pending·0 cites
- 4352US2015031050A1Method of Screening Therapeutic Agent for Treating Inflammatory DiseasesUNIV MACAU SCI & TECH·Filed 2014·Application pending·0 cites
- 4451US9955676B2Transgenic model for delay-type hypersensitivity (DTH) and use thereofUNIV MACAU SCI & TECH·Filed 2015·Granted May 1, 2018·0 cites·10 claims
- 4550US10234454B2Use of glycan as biomarkers for autoimmune diseasesUNIV MACAU SCI & TECH·Filed 2015·Granted Mar 19, 2019·0 cites·9 claims
- 4649US9597299B2Method for treating gefitinib-resistant non-small-cell lung cancerUNIV MACAU SCI & TECH·Filed 2015·Granted Mar 21, 2017·0 cites·15 claims
- 4749US7419960B2Hemiterpene glycosides with anti-platelet aggregation activities from Ilex pubescensUNIV HONG KONG BAPTIST·Filed 2005·Granted Sep 2, 2008·0 cites·6 claims
- 4849US2017143668A1Use of nobiletin in cancer treatmentUNIV MACAU SCI & TECH·Filed 2017·Application pending·0 cites
- 4948US2006110468A1Herbal formulations for arthritisLIU LIANG·Filed 2004·Application pending·0 cites
- 5047US10111876B2ALK Kinase Inhibitor and its useUNIV MACAU SCI & TECH·Filed 2016·Granted Oct 30, 2018·0 cites·5 claims
Showing the top 50 of 71 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Liang Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →